Treatment of metastatic non-small cell lung cancer: 2018 guidelines of the Italian Association of Medical Oncology (AIOM).

Antineoplastic Agents / therapeutic use Carcinoma, Non-Small-Cell Lung / drug therapy Health Personnel / standards Humans Italy Lung Neoplasms / drug therapy Medical Oncology / standards
AIOM guidelines non-small cell lung cancer recommendations

Journal

Tumori
ISSN: 2038-2529
Titre abrégé: Tumori
Pays: United States
ID NLM: 0111356

Informations de publication

Date de publication:
Jul 2019
Historique:
entrez: 3 7 2019
pubmed: 3 7 2019
medline: 10 7 2019
Statut: ppublish

Résumé

The treatment landscape of metastatic non-small cell lung cancer (NSCLC) has dramatically evolved in recent years, since the recognition of several clinical-biological entities requiring personalized treatment approaches, leading to significant improvements in patients' survival outcomes. In particular, targeted therapies acting against

Identifiants

DOI: 10.1177/0300891619857418 PMID: 31264531
pubmed: 31264531
doi: 10.1177/0300891619857418
doi:

Substances chimiques

Antineoplastic Agents 0

Types de publication

Journal Article Meta-Analysis Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

3-14

Auteurs

Francesco Facchinetti (F)

1 INSERM U981, Gustave Roussy Cancer Campus, Université Paris Saclay, Villejuif, France.

Sara Pilotto (S)

2 Medical Oncology, University of Verona, Verona University Hospital, Verona, Italy.

Giulio Metro (G)

3 Medical Oncology, Santa Maria della Misericordia Hospital, Azienda Ospedaliera di Perugia, Perugia, Italy.

Editta Baldini (E)

4 Department of Oncology, S. Luca Hospital, Lucca, Italy.

Luca Bertolaccini (L)

5 Division of Thoracic Surgery, IEO, European Institute of Oncology IRCCS, Milan, Italy.

Federico Cappuzzo (F)

6 Department of Oncology and Hematology, AUSL Romagna, Ravenna, Italy.

Angelo Delmonte (A)

7 Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy.

Stefano Gasparini (S)

8 Department of Biologic Sciences and Public Health, Polytechnic University of Marche Region; Pulmonary Diseases Unit, Azienda Ospedali Riuniti, Ancona, Italy.

Alessandro Inno (A)

9 Medical Oncology, IRCCS Ospedale Sacro Cuore Don Calabria, Negrar, Verona, Italy.

Antonio Marchetti (A)

10 Center of Predictive Molecular Medicine, Center of Excellence on Aging University-Foundation, Chieti, Italy.

Francesco Passiglia (F)

11 Department of Oncology, University of Turin, San Luigi Hospital, Orbassano, Italy.

Francesco Puma (F)

12 Division of Thoracic Surgery, S. Maria della Misericordia Hospital, University of Perugia Medical School, Perugia, Italy.

Umberto Ricardi (U)

13 Radiation Oncology, Department of Oncology, University of Torino, Torino, Italy.

Antonio Rossi (A)

14 Division of Medical Oncology, Fondazione IRCCS "Casa Sollievo della Sofferenza," San Giovanni Rotondo, Foggia, Italy.

Lucio Crinò (L)

7 Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy.

Silvia Novello (S)

11 Department of Oncology, University of Turin, San Luigi Hospital, Orbassano, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Actions chimiques et utilisations › Actions pharmacologiques › Utilisations thérapeutiques › Antinéoplasiques › Treatment of metastatic non-small cell lung...
questionsmedicales.fr › Maladies de l'appareil respiratoire › Tumeurs de l'appareil respiratoire › Tumeurs du poumon › Tumeurs des bronches › Carcinome bronchogénique › Carcinome pulmonaire non à petites cellules › Treatment of metastatic non-small cell lung...
questionsmedicales.fr › Établissements, main d'oeuvre et services de soins de santé › Personnel de santé › Treatment of metastatic non-small cell lung...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Treatment of metastatic non-small cell lung...
questionsmedicales.fr › Régions géographiques › Europe › Italie › Treatment of metastatic non-small cell lung...
questionsmedicales.fr › Maladies de l'appareil respiratoire › Tumeurs de l'appareil respiratoire › Tumeurs du poumon › Treatment of metastatic non-small cell lung...
questionsmedicales.fr › Professions de santé › Médecine › Médecine interne › Oncologie médicale › Treatment of metastatic non-small cell lung...